Velcade and hypoaesthesia Patient Reports February 11, 2012

Velcade Side Effects Report #4616557-1
Velcade side effect was reported by a Consumer or non-health professional from on Nov 18, 2004. Female patient, 88 years of age, weighting 175.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: arthralgia, hypoaesthesia, paraesthesia. Velcade dosage: unknown. Patient recovered.

Velcade Side Effects Report #4771177-3
Velcade side effect was reported by a Consumer or non-health professional from UNITED STATES on July 25, 2005. Female patient, 88 years of age, weighting 175.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: arthralgia, hypoaesthesia, paraesthesia. Velcade dosage: unknown. Patient recovered.

Velcade Side Effects Report #5451068-5
Velcade side effect was reported by a Physician from JAPAN on Aug 28, 2007. Female patient, 83 years of age, weighting 83.78 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal distension, ascites, disease progression, hypoaesthesia, hyponatraemia, liver disorder, neoplasm progression, nerve injury, neuropathy. Velcade dosage: 1.30 MG/M2; 1.00 MG/M2,. During the same period patient was treated with DECADRON, BAKTAR, DIFLUCAN, MUCOSTA, POLYMYXIN B SULPHATE, OMEPRAL, MAGNESIUM OXIDE. Patient was hospitalized and became disabled. Patient died on 05/27/2007.

Velcade Side Effects Report #4881254-4
Velcade side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 21, 2005. Female patient, 83 years of age, weighting 125.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: haemorrhage, hypoaesthesia, pain in extremity, platelet count decreased. Velcade dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.


Velcade Side Effects Report #4992448-1
Velcade side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 10, 2006. Female patient, 83 years of age, weighting 125.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: haemorrhage, hypoaesthesia, pain in extremity, platelet count decreased. Velcade dosage: 1.20 MG/M2, INTRAVENOUS. Patient was hospitalized and became disabled. Patient recovered.

Velcade Side Effects Report #5517828-7
Velcade side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 01, 2007. Female patient, 80 years of age, weighting 115.1 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: angiopathy, cataract , hypoaesthesia, neuropathy peripheral, presyncope, reversible posterior leukoencephalopathy syndrome, sensation of heaviness, thrombocytopenia. Velcade dosage: 1.30 MG/M2 ; 1.00 MG. During the same period patient was treated with LISINOPRIL, LIPITOR, ASPIRIN. Patient recovered.

Velcade Side Effects Report #5958815-4
Velcade side effect was reported by a Physician from UNITED STATES on Nov 04, 2008. Female patient, 79 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: asthenia, constipation , cranial nerve disorder, diarrhoea, diarrhoea haemorrhagic, dysstasia, fatigue, hypoaesthesia, intestinal ischaemia. Velcade dosage: 1.3 MG/M2. During the same period patient was treated with MELPHALAN, PREDNISONE, VITAMIN B12, AREDIA. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #6104723-8
Velcade side effect was reported by a Physician from UNITED STATES on Feb 19, 2009. Male patient, 78 years of age, weighting 168.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood count abnormal, demyelinating polyneuropathy, fall , hypoaesthesia, muscular weakness, pain , paraesthesia, urinary tract disorder. Velcade dosage: 2.4 MG/M2. During the same period patient was treated with DECADRON, ZOFRAN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #6136797-2
Velcade side effect was reported by a Physician from UNITED STATES on Mar 17, 2009. Male patient, 78 years of age, weighting 168.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: asthenia, atonic urinary bladder, demyelinating polyneuropathy, fall , hypoaesthesia, hyponatraemia, pain , paraesthesia, platelet count decreased. Velcade dosage: 2.4 MG/M2,. During the same period patient was treated with DECADRON, ZOFRAN. Patient was hospitalized and became disabled. Patient recovered.


Velcade Side Effects Report #5602195-0
Velcade side effect was reported by a Physician from JAPAN on Jan 10, 2008. Male patient, 77 years of age, weighting 119.0 lb, was diagnosed with multiple myeloma , prophylaxis, platelet count decreased and was treated with Velcade. After drug was administered, patient experienced the following side effects: constipation , erythema multiforme, hiccups, hypoaesthesia, hypotension, lymphopenia, platelet count decreased, upper respiratory tract inflammation, viral infection . Velcade dosage: 2.00 MG, INTRAVENOUS; 1.60 MG, INTRAVENOUS. During the same period patient was treated with ACYCLOVIR, BAKTAR, PLATELETS, DEXAMETHASONE, ALLOPURINOL, ZANTAC, MUCOSTA. Patient recovered.

Velcade Side Effects Report #5856742-4
Velcade side effect was reported by a Physician from JAPAN on Aug 12, 2008. Female patient, 77 years of age, weighting 112.4 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal distension, constipation , diarrhoea, herpes zoster, hypoaesthesia, hyponatraemia. Velcade dosage: 1.3 MG, INTRAVENOUS; 1.7 MG, INTRAVENOUS. During the same period patient was treated with DECADRON SRC, DEXAMETHASONE PHOSPHATE, AMLODIPINE BESYLATE, LISINOPRIL, MARZULENE S, ALTAT. Patient recovered.

Velcade Side Effects Report #5877542-5
Velcade side effect was reported by a Physician from JAPAN on Aug 27, 2008. Female patient, 77 years of age, weighting 112.4 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal distension, constipation , diarrhoea, fall , gastrointestinal hypomotility, herpes zoster, hypoaesthesia, hyponatraemia, orthostatic hypotension. Velcade dosage: 1.7 MG, INTRAVENOUS; 0.9 MG, INTRAVENOUS; 1.3 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE PHOSPHATE, AMLODIPINE BESYLATE, LISINOPRIL, MARZULENE S. Patient recovered.

Velcade Side Effects Report #5894627-8
Velcade side effect was reported by a Physician from JAPAN on Sept 10, 2008. Female patient, 77 years of age, weighting 112.4 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal distension, constipation , diarrhoea, erythema, fall , gastrointestinal hypomotility, herpes zoster, hypoaesthesia, hyponatraemia. Velcade dosage: unknown. During the same period patient was treated with DEXAMETHASONE PHOSPHATE, AMLODIPINE BESYLATE, LISINOPRIL, MARZULENE S. Patient recovered.

Velcade Side Effects Report #5448212-2
Velcade side effect was reported by a Physician from JAPAN on Aug 23, 2007. Female patient, 75 years of age, weighting 103.6 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: bone pain, face oedema, hypoaesthesia, hyponatraemia, malaise, optic nerve disorder. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, DIFLUCAN, BAKTAR, ALLOPURINOL, ALFAROL, OMEPRAZOLE, PROMAC, KAMAG G. Patient was hospitalized. Patient recovered.


Velcade Side Effects Report #5458045-9
Velcade side effect was reported by a Physician from JAPAN on Sept 05, 2007. Female patient, 75 years of age, weighting 97.00 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, hypoaesthesia, nausea , neutrophil count decreased, platelet count decreased, pyrexia. Velcade dosage: 1.66 MG, INTRAVENOUS; 1.28 MG, INTRAVENOUS. During the same period patient was treated with ACTONEL, METHYCOBAL, URALYT, KYTRIL. Patient recovered.

Velcade Side Effects Report #5458124-6
Velcade side effect was reported by a Physician from JAPAN on Sept 06, 2007. Female patient, 75 years of age, weighting 103.6 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: bone pain, face oedema, hypoaesthesia, hyponatraemia, malaise, optic nerve disorder. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, DIFLUCAN, BAKTAR, ALLOPURINOL, ALFAROL, OMEPRAZOLE, PROMAC, KAMAG G. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5480956-9
Velcade side effect was reported by a Physician from JAPAN on Sept 26, 2007. Female patient, 75 years of age, weighting 97.00 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, hypoaesthesia, nausea , neutrophil count decreased, platelet count decreased, pyrexia. Velcade dosage: 1.66 MG, INTRAVENOS, 1.28 MG, INTRAVENOUS. During the same period patient was treated with ACTONEL, METHYCOBAL, URALYT, KYTRIL. Patient recovered.

Velcade Side Effects Report #5534927-4
Velcade side effect was reported by a Physician from JAPAN on Nov 21, 2007. Male patient, 75 years of age, weighting 127.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal distension, anorexia, antibody test positive, constipation , diarrhoea, hypertension, hypoaesthesia, interstitial lung disease, movement disorder . Velcade dosage: 2.20 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, ALFAROL, PURSENNID, MAGNESIUM OXIDE, LANSOPRAZOLE, KYTRIL, POLYETHYLENE GLYCOL, LOPERAMIDE. Patient was hospitalized and became disabled. Patient recovered.

Velcade Side Effects Report #4881348-3
Velcade side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 26, 2005. Male patient, 75 years of age, weighting 162.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: hypoaesthesia, paraesthesia. Velcade dosage: unknown. During the same period patient was treated with HYDROCODONE BITARTRATE, PREVACID, TYLENOL PM, ALLEGRA, BENADRYL, MILK OF MAGNESIA, DULCOLAX, TEGASEROD. Patient recovered.


Velcade Side Effects Report #4990691-9
Velcade side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 10, 2006. Male patient, 75 years of age, weighting 162.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: hypoaesthesia, paraesthesia. Velcade dosage: 2.40 MG ; 1.50 MG ; 2.40 MG. During the same period patient was treated with HYDROCODONE BITARTRATE, PREVACID, TYLENOL PM, ALLEGRA, BENADRYL, MILK OF MAGNESIA. Patient recovered.

Velcade Side Effects Report #5642145-4
Velcade side effect was reported by a Physician from JAPAN on Feb 13, 2008. Male patient, 74 years of age, weighting 101.4 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: constipation , disease progression, hypoaesthesia, nausea , pneumonia aspiration, pyrexia, thrombocytopenia. Velcade dosage: 1.80 MG, INTRAVENOUS; 1.40 MG, INTRAVENOUS. During the same period patient was treated with HYDROCORTISONE SUCCINATE, NIFEDIPINE, PROTECADIN, ALLOPURINOL, BICARBONATE, SOLITA T, PRIMPERAN. Patient died on 10/23/2007.

Velcade Side Effects Report #5663527-0
Velcade side effect was reported by a Physician from JAPAN on Feb 22, 2008. Male patient, 74 years of age, weighting 101.4 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: altered state of consciousness, constipation , diarrhoea, disease progression, hypoaesthesia, nausea , pneumonia aspiration, renal impairment, thrombocytopenia. Velcade dosage: 1.80 MG, INTRAVENOUS; 1.40 MG, INTRAVENOUS; 1.00 MG, INTRAVENOUS. During the same period patient was treated with HYDROCORTISONE SUCCINATE, NIFEDIPINE, PROTECADIN, ALLOPURINOL, BICARBONATE, SOLITA T. Patient was hospitalized. Patient died on 10/23/2007.

Velcade Side Effects Report #5746656-2
Velcade side effect was reported by a Physician from JAPAN on May 08, 2008. Male patient, 74 years of age, weighting 119.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: hypoaesthesia. Velcade dosage: 1.3 MG/M2, INTRAVENOUS. Patient recovered.

Velcade Side Effects Report #5981835-0
Velcade side effect was reported by a Physician from UNITED STATES on Nov 17, 2008. Female patient, 74 years of age, weighting 166.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: back pain , depression , disease progression, disease recurrence, fatigue, glossodynia, hypoaesthesia, neutropenia, no therapeutic response. Velcade dosage: 1 MG/M2, INTRAVENOUS. During the same period patient was treated with THALIDOMIDE, DEXAMETHASONE, XANAX, LACTULOSE, SONATA, EFFEXOR. Patient recovered.


Velcade Side Effects Report #6029111-4
Velcade side effect was reported by a Physician from JAPAN on Dec 24, 2008. Male patient, 74 years of age, weighting 116.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: abasia, anaemia, bacterial infection , c-reactive protein increased, disease progression, hypersensitivity, hypoaesthesia, hypokalaemia, leukopenia. Velcade dosage: 2 MG, INTRAVENOUS. During the same period patient was treated with ADRIAMYCIN PFS, DEXAMETHASONE, AREDIA, MAXIPIME, PLATELETS, POLARAMINE, KYTRIL, LASIX. Patient died on 07/22/2008.

Velcade Side Effects Report #4692503-X
Velcade side effect was reported by a Pharmacist from on Feb 14, 2005. Female patient, 74 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: hypoaesthesia, neuropathy peripheral, pain in extremity, paraesthesia. Velcade dosage: 2.40 MG, INTRAVENOUS. Patient recovered.

Velcade Side Effects Report #5612811-5
Velcade side effect was reported by a Physician from JAPAN on Jan 24, 2008. Male patient, 73 years of age, weighting 138.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: constipation , disease progression, hypoaesthesia, platelet count decreased, rash . Velcade dosage: 2.00 MG, INTRAENOUS, 1.50 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, LOXOPROFEN, MUCOSTA, FLUCONAZOLE, BAKTAR, MAGNESIUM OXIDE, FAMOTIDINE. Patient died.

Velcade Side Effects Report #5622327-8
Velcade side effect was reported by a Physician from JAPAN on Jan 25, 2008. Male patient, 73 years of age, weighting 138.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: constipation , disease progression, hypoaesthesia, platelet count decreased, rash . Velcade dosage: 2.00 MG, INTRAVENOUS : 1.50 MG, INTRAVENOUS : 1.00 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, LOXOPROFEN, MUCOSTA, FLUCONAZOLE, BAKTAR, MAGNESIUM OXIDE. Patient died on 01/06/2008.

Velcade Side Effects Report #5719059-4
Velcade side effect was reported by a Physician from JAPAN on Apr 14, 2008. Male patient, 73 years of age, weighting 138.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: constipation , disease progression, hypoaesthesia, platelet count decreased, rash . Velcade dosage: 2.00 MG, INTRAVENOUS; 1.50 MG, INTRAVENOUS; 1.00 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, LOXOPROFEN, MUCOSTA, FLUCONAZOLE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, MAGNESIUM OXIDE. Patient died on 01/06/2008.


Velcade Side Effects Report #5692802-9
Velcade side effect was reported by a Physician from JAPAN on Mar 25, 2008. Female patient, 72 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood glucose increased, cardiac failure, cardiogenic shock, diarrhoea, hypoaesthesia, pulmonary oedema. Velcade dosage: 1.30 MG/M2; INTRAVENOUS. During the same period patient was treated with DECADRON. Patient died on 03/21/2008.

Velcade Side Effects Report #5705321-8
Velcade side effect was reported by a Physician from JAPAN on Mar 31, 2008. Female patient, 72 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: blood glucose increased, cardiac failure, cardiogenic shock, hypoaesthesia, pulmonary oedema. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DECADRON. Patient died on 03/21/2008.

Velcade Side Effects Report #5714120-2
Velcade side effect was reported by a Physician from JAPAN on Apr 08, 2008. Female patient, 72 years of age, weighting 108.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, cardiac failure congestive, cardiogenic shock, condition aggravated, diarrhoea, hyperglycaemia, hypoaesthesia, no therapeutic response. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DECADRON. Patient died on 03/21/2008.

Velcade Side Effects Report #5843041-X
Velcade side effect was reported by a Physician from JAPAN on July 29, 2008. Female patient, 72 years of age, weighting 108.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, cardiac failure congestive, cardiogenic shock, diarrhoea, hyperglycaemia, hypoaesthesia, platelet count decreased. Velcade dosage: 1.30 MG/M2 UNK INTRAVENOUS. During the same period patient was treated with DECADRON, RED BLOOD CELLS. Patient died on 03/21/2008.

Velcade Side Effects Report #5955798-8
Velcade side effect was reported by a Physician from JAPAN on Oct 28, 2008. Female patient, 72 years of age, weighting 108.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: cardiac failure congestive, cardiogenic shock, diarrhoea, hyperglycaemia, hypoaesthesia, no therapeutic response, pulmonary oedema. Velcade dosage: 1.8 MG, INTRAVENOUS. During the same period patient was treated with DECADRON. Patient died on 03/21/2008.


Velcade Side Effects Report #4769769-0
Velcade side effect was reported by a Health Professional from UNITED STATES on Aug 10, 2005. Male patient, 72 years of age, weighting 282.2 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: dizziness , hypoaesthesia, neuropathy, paraesthesia. Velcade dosage: 2.6 MG, IV BOLUS. Patient recovered.

Velcade Side Effects Report #4990679-8
Velcade side effect was reported by a Health Professional from UNITED STATES on Nov 29, 2005. Male patient, 72 years of age, weighting 282.2 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: dizziness , hypoaesthesia, neuropathy, paraesthesia. Velcade dosage: 2.6 MG, IV BOLUS. Patient recovered.

Velcade Side Effects Report #5334743-2
Velcade side effect was reported by a Consumer or non-health professional from UNITED STATES on May 07, 2007. Male patient, 71 years of age, weighting 160.1 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , diarrhoea, disturbance in attention, hypoaesthesia, hypogeusia, hyposmia, neuropathy, somnolence, ventricular tachycardia. Velcade dosage: unknown. During the same period patient was treated with ZOMETA, ACYCLOVIR, NORVASC, ALLEGRA, DIFLUCAN, PANTOPRAZOLE, TOPROL. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5165805-0
Velcade side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 14, 2006. Male patient, 71 years of age, weighting 160.1 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: atrial fibrillation , diarrhoea, disturbance in attention, hypoaesthesia, hypogeusia, hyposmia, neuropathy, somnolence, ventricular tachycardia. Velcade dosage: unknown. During the same period patient was treated with ZOMETA, ACYCLOVIR, NORVASC, ALLEGRA, DIFLUCAN, PANTOPRAZOLE, TOPROL. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5622912-3
Velcade side effect was reported by a Physician from JAPAN on Jan 28, 2008. Female patient, 71 years of age, weighting 83.78 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, hypoaesthesia. Velcade dosage: 1.60 MG, INTRAVENOUS. During the same period patient was treated with MAGNESIUM OXIDE, SELBEX, NIZATIDINE, DIFLUCAN, ZOMETA. Patient died on 08/12/2007.


Velcade Side Effects Report #5746163-7
Velcade side effect was reported by a Physician from JAPAN on May 08, 2008. Male patient, 71 years of age, weighting 125.7 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, blood uric acid increased, diarrhoea, eosinophilia, gait disturbance, hypoaesthesia, hypokalaemia. Velcade dosage: 2 MG, INTRAVENOUS; 1.5 MG, INTRAVENOUS. During the same period patient was treated with GLYBURIDE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #6029384-8
Velcade side effect was reported by a Physician from JAPAN on Dec 25, 2008. Male patient, 71 years of age, weighting 125.7 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood urea increased, diarrhoea, gait disturbance, hypoaesthesia, hypokalaemia, platelet count decreased, renal failure. Velcade dosage: 2 MG, INTRAVENOUS; 1.5 MG, INTRAVENOUS. During the same period patient was treated with GLYBURIDE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4685975-8
Velcade side effect was reported by a Health Professional from on Feb 24, 2005. Female patient, 71 years of age, weighting 157.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: cerebrovascular accident, facial palsy, hypoaesthesia, paraesthesia, speech disorder. Velcade dosage: 2.30 MG, 2/WEEK, IV BOLUS. During the same period patient was treated with KYTRIL, AREDIA. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5809730-8
Velcade side effect was reported by a Physician from JAPAN on June 28, 2008. Female patient, 70 years of age, weighting 143.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, graft versus host disease, hypoaesthesia, hyponatraemia, neutrophil count decreased, platelet count decreased. Velcade dosage: 2.00 MG. During the same period patient was treated with PREDONINE, NEORAL. Patient was hospitalized. Patient died on 04/27/2008.

Velcade Side Effects Report #5451074-0
Velcade side effect was reported by a Physician from JAPAN on Aug 27, 2007. Female patient, 69 years of age, weighting 149.9 lb, was diagnosed with multiple myeloma , angina pectoris and was treated with Velcade. After drug was administered, patient experienced the following side effects: anxiety , bundle branch block, hypoaesthesia, hypotension, irritability, platelet count decreased. Velcade dosage: 2.30 MG, INTRAVENOUS. During the same period patient was treated with CARVEDILOL, VERAPAMIL HYDROCHLORIDE, DEXAMETHASONE, OXYCONTIN, MORPHINE, FENTANYL, URSO, MAGNESIUM OXIDE. Patient recovered.

Velcade Side Effects Report #5477532-0
Velcade side effect was reported by a Physician from JAPAN on Sept 21, 2007. Female patient, 69 years of age, weighting 149.9 lb, was diagnosed with multiple myeloma , angina pectoris and was treated with Velcade. After drug was administered, patient experienced the following side effects: anxiety , bundle branch block, disease progression, hypoaesthesia, hypotension, irritability, platelet count decreased. Velcade dosage: 2.30 MG UNK INTRAVENOUS. During the same period patient was treated with CARVEDILOL, VERAPAMIL HYDROCHLORIDE, DEXAMETHASONE, OXYCONTIN, MORPHINE, FENTANYL, URSO, MAGNESIUM OXIDE. Patient recovered.

Velcade Side Effects Report #5484425-1
Velcade side effect was reported by a Physician from JAPAN on Oct 01, 2007. Female patient, 69 years of age, weighting 149.9 lb, was diagnosed with multiple myeloma , angina pectoris and was treated with Velcade. After drug was administered, patient experienced the following side effects: anxiety , bundle branch block, disease progression, hypoaesthesia, hypotension, irritability, platelet count decreased. Velcade dosage: 2.30 MG, INTRAVENOUS. During the same period patient was treated with CARVEDILOL, VERAPAMIL HYDROCHLORIDE, DEXAMETHASONE, OXYCONTIN, MORPHINE, FENTANYL, URSO, MAGNESIUM OXIDE. Patient recovered.

Velcade Side Effects Report #5809723-0
Velcade side effect was reported by a Physician from BRAZIL on June 30, 2008. Male patient, 69 years of age, weighting 145.5 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: hypoaesthesia, oedema peripheral, pain in extremity, paralysis , skin burning sensation. Velcade dosage: 3.5 MG, INTRAVENOUS. During the same period patient was treated with TRAMADOL. Patient recovered.

Velcade Side Effects Report #5955701-0
Velcade side effect was reported by a Physician from JAPAN on Oct 29, 2008. Female patient, 69 years of age, weighting 110.2 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: atelectasis, fall , hypoaesthesia, neuropathy peripheral, platelet count decreased, subarachnoid haemorrhage, traumatic haematoma. Velcade dosage: 1 MG/M2, INTRAVENOUS. Patient recovered.

Velcade Side Effects Report #5975235-7
Velcade side effect was reported by a Physician from ARGENTINA on Nov 20, 2008. Female patient, 69 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: abasia, hearing impaired, hypoaesthesia, neuropathy peripheral, paraesthesia, vision blurred, visual acuity reduced. Velcade dosage: unknown. Patient recovered.


Velcade Side Effects Report #5494544-1
Velcade side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 10, 2007. Male patient, 68 years of age, weighting 233.0 lb, was diagnosed with multiple myeloma , thrombosis and was treated with Velcade. After drug was administered, patient experienced the following side effects: asthenia, balance disorder, confusional state, diarrhoea, dizziness , dyspnoea, headache , hypoaesthesia, increased tendency to bruise. Velcade dosage: unknown. During the same period patient was treated with WARFARIN, LOVENOX, NEXIUM, LIPITOR, LEXAPRO. Patient recovered.

Velcade Side Effects Report #4748413-2
Velcade side effect was reported by a Health Professional from UNITED STATES on Aug 02, 2005. Male patient, 67 years of age, weighting 179.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal pain upper, alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, hypoaesthesia, pyrexia, rhinorrhoea, thrombocytopenia. Velcade dosage: unknown. During the same period patient was treated with DEXAMETHASONE, PRAVACHOL, COLCHICINE. Patient recovered.

Velcade Side Effects Report #5504697-4
Velcade side effect was reported by a Physician from JAPAN on Oct 19, 2007. Male patient, 66 years of age, weighting 147.7 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, blood lactate dehydrogenase increased, constipation , enterocolitis, hypoaesthesia, lymphocyte count decreased, neutrophil count decreased, oedema. Velcade dosage: 2.00 MG, INTRAVENOUS, 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DECADRON, LEVOFLOXACIN, BAKTAR, LAXOBERON, SENNOSIDE A, PANTOSIN, PLATELETS. Patient recovered.

Velcade Side Effects Report #5584731-6
Velcade side effect was reported by a Physician from JAPAN on Dec 19, 2007. Male patient, 66 years of age, weighting 147.7 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, blood lactate dehydrogenase increased, constipation , disease progression, enterocolitis, hypoaesthesia, lymphocyte count decreased, malignant neoplasm progression. Velcade dosage: 2.00 MG, INTRAVENOUS : 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DECADRON, LEVOFLOXACIN, BAKTAR, LAXOBERON, SENNOSIDE A, PANTOSIN, PLATELETS. Patient recovered.

Velcade Side Effects Report #5592459-1
Velcade side effect was reported by a Physician from ITALY on Jan 02, 2008. Male patient, 66 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: asthenia, csf test abnormal, disease progression, hypoaesthesia, neurological symptom. Velcade dosage: unknown. Patient died on 04/08/2007.

Velcade Side Effects Report #4692488-6
Velcade side effect was reported by a Consumer or non-health professional from on Feb 22, 2005. Female patient, 66 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: hypoaesthesia, neuropathy peripheral, pain . Velcade dosage: unknown. Patient recovered.

Velcade Side Effects Report #5369307-8
Velcade side effect was reported by a Physician from JAPAN on June 14, 2007. Male patient, 65 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: herpes zoster, hypoaesthesia, nausea , platelet count decreased, urinary tract infection . Velcade dosage: unknown. During the same period patient was treated with DEXAMETHASONE, PRIMPERAN, SULFAMETHOXAZOLE, CIPROXAN, BASEN, AMARYL, LANSOPRAZOLE, MAGNESIUM OXIDE. Patient recovered.

Velcade Side Effects Report #5384658-9
Velcade side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 04, 2007. Female patient, 65 years of age, weighting 100.1 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: gait disturbance, hypoaesthesia. Velcade dosage: unknown. Patient recovered.

Velcade Side Effects Report #5390874-2
Velcade side effect was reported by a Physician from JAPAN on July 04, 2007. Male patient, 65 years of age, weighting 130.1 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, herpes zoster, hypoaesthesia, nausea , platelet count decreased, urinary tract infection . Velcade dosage: 1.00 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, PIMPERAN, SULFAMETHOXAZOLE, CIPROXAN, BASEN, AMARYL, LANSOPRAZOLE, MAGNESIUM OXIDE. Patient recovered.

Velcade Side Effects Report #5429342-8
Velcade side effect was reported by a Physician from JAPAN on Aug 16, 2007. Male patient, 65 years of age, weighting 130.1 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, herpes zoster, hypoaesthesia, nausea , platelet count decreased, urinary tract infection . Velcade dosage: 1.00 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, PRIMPERAN, BAKTAR, CIPROXAN, BASEN, AMARYL, LANSOPRAZOLE, MAGNESIUM OXIDE. Patient recovered.


Velcade Side Effects Report #5429342-8
Velcade side effect was reported by a Physician from JAPAN on Aug 16, 2007. Male patient, 65 years of age, weighting 130.1 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, herpes zoster, hypoaesthesia, nausea , platelet count decreased, urinary tract infection . Velcade dosage: 1.00 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, PRIMPERAN, BAKTAR, CIPROXAN, BASEN, AMARYL, LANSOPRAZOLE, MAGNESIUM OXIDE. Patient recovered.

Velcade Side Effects Report #5592365-2
Velcade side effect was reported by a Physician from ITALY on Jan 02, 2008. Male patient, 65 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: disease progression, hypoaesthesia, neurological symptom, paraparesis. Velcade dosage: unknown. Patient died on 06/19/2006.

Velcade Side Effects Report #5617250-9
Velcade side effect was reported by a Physician from JAPAN on Jan 24, 2008. Male patient, 65 years of age, weighting 130.1 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, hepatic function abnormal, herpes zoster, hypoaesthesia, nausea , platelet count decreased, pyrexia, urinary tract infection . Velcade dosage: 1.00 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, PRIMPERAN, BAKTAR, CIPROFLOXACIN, BASEN, AMARYL, LANSOPRAZOLE, MAGNESIUM OXIDE. Patient recovered.

Velcade Side Effects Report #5804284-4
Velcade side effect was reported by a Physician from JAPAN on June 25, 2008. Male patient, 65 years of age, weighting 130.1 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, blood urea increased, hepatic function abnormal, herpes zoster, hypoaesthesia, nausea , platelet count decreased. Velcade dosage: 1.5 MG, INTRAVENOUS; 1.1 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, PRIMPERAN, SULFAMETHOXAZOLE AND TRIMETHOPRIM, CIPROXAN, BASEN, AMARYL, LANSOPRAZOLE. Patient recovered.

Velcade Side Effects Report #4695771-3
Velcade side effect was reported by a Physician from on June 20, 2005. Male patient, 65 years of age, weighting 220.5 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: asthenia, back pain , confusional state, dysstasia, fall , hypoaesthesia, hyponatraemia, inappropriate antidiuretic hormone secretion, incoherent. Velcade dosage: 1.3 MG/M2 IV BOLUS. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5578235-4
Velcade side effect was reported by a Physician from JAPAN on Dec 11, 2007. Male patient, 64 years of age, weighting 138.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal pain , anaemia, ascites, cholecystitis chronic, diarrhoea, fluid retention, hypoaesthesia, oedema peripheral. Velcade dosage: 1.90 MG, INTRAVENOUS; 1.50 MG, INTRAVENOUS. During the same period patient was treated with DECADRON, LASIX, DEXAMETHASONE, KYTRILL, BICARBONATE, FAMOTIDINE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5617253-4
Velcade side effect was reported by a Physician from JAPAN on Jan 24, 2008. Male patient, 64 years of age, weighting 138.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal pain , anaemia, ascites, cholecystitis chronic, diarrhoea, hypoaesthesia, oedema peripheral, platelet count decreased. Velcade dosage: 1.90 MG, INTRAVENOUS; 1.50MG, INTRAVENOUS. During the same period patient was treated with DECADRON, LASIX, DEXAMETHASONE, KYTRIL, BICARBONATE, FAMOTIDINE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5894994-5
Velcade side effect was reported by a Physician from JAPAN on Sept 10, 2008. Male patient, 64 years of age, weighting 121.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: diarrhoea, disease progression, haemoglobin decreased, hypoaesthesia, lymphocyte count decreased, pneumonia influenzal, pyrexia, renal impairment. Velcade dosage: 1.6 MG, UNK, INTRAVENOUS, 2.1 MG, UNK, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, PARIET, LENDORM, DIFLUCAN, UBRETID. Patient died on 11/24/2007.

Velcade Side Effects Report #5937664-7
Velcade side effect was reported by a Physician from JAPAN on Oct 17, 2008. Male patient, 64 years of age, weighting 121.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: diarrhoea, disease progression, haemoglobin decreased, hypoaesthesia, lymphocyte count decreased, multiple myeloma , pneumonia influenzal, renal impairment. Velcade dosage: 1.6 MG, INTRAVENOUS, 2.1 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, PARIET, LENDORM, DIFLUCAN, NAIXAN. Patient died on 11/24/2007.

Velcade Side Effects Report #5937702-1
Velcade side effect was reported by a Physician from JAPAN on Oct 17, 2008. Female patient, 64 years of age, weighting 105.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: aspergillosis, bedridden, bone marrow failure, cytomegalovirus infection , grip strength decreased, hypoaesthesia, muscular weakness, neuralgia. Velcade dosage: 1.4 MG, INTRAVENOUS. During the same period patient was treated with DECADRON. Patient died on 09/13/2008.


Velcade Side Effects Report #4769145-0
Velcade side effect was reported by a Health Professional from UNITED STATES on Aug 01, 2005. Male patient, 63 years of age, weighting 174.2 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: burning sensation, hypoaesthesia, infusion site erythema, oedema peripheral, orthostatic hypotension, pancytopenia, paraesthesia. Velcade dosage: 1.30 MG/M2, INTRAVENOUS; SEE IMAGE. During the same period patient was treated with DOXIL, ACYCLOVIR, TOPROL, LISINOPRIL, LEXAPROL, AREDIA. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5214709-3
Velcade side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Jan 03, 2007. Male patient, 62 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: feeling hot, hypoaesthesia, metabolic acidosis, neuropathy, pleural effusion, pneumonia , respiratory alkalosis, septic shock. Velcade dosage: 2.20 MG. Patient was hospitalized. Patient died on 12/29/2006.

Velcade Side Effects Report #5398443-5
Velcade side effect was reported by a Physician from JAPAN on July 10, 2007. Female patient, 62 years of age, weighting 94.80 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood chloride decreased, diarrhoea, hypoaesthesia, hyponatraemia, platelet count decreased, pyrexia. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, OMEPRAL, ITRACONAZOLE, BAKTAR, ALLOPURINOL. Patient recovered.

Velcade Side Effects Report #5420099-3
Velcade side effect was reported by a Physician from JAPAN on Aug 03, 2007. Female patient, 62 years of age, weighting 94.80 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood chloride decreased, diarrhoea, hypoaesthesia, hyponatraemia, platelet count decreased, pyrexia. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, OMEPRAL, ITRIZOLE, BAKTAR, ALLOPURINOL, PLATELETS. Patient recovered.

Velcade Side Effects Report #5455054-0
Velcade side effect was reported by a Physician from JAPAN on Sept 03, 2007. Female patient, 62 years of age, weighting 94.80 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood chloride decreased, condition aggravated, diarrhoea, hypoaesthesia, hyponatraemia, platelet count decreased, pyrexia. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, OMEPRAL, ITRACONAZOLE, BAKTAR, ALLOPURINOL, PLATELETS. Patient recovered.

Velcade Side Effects Report #5332056-6
Velcade side effect was reported by a Physician from JAPAN on May 10, 2007. Female patient, 61 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: deep vein thrombosis , haemoglobin decreased, hypoaesthesia, platelet count decreased, pulmonary infarction. Velcade dosage: 1.80 MG,. During the same period patient was treated with DEXAMETHASONE, PREDNISOLONE, SULFAMETHOXAZOLE, DIFLUCAN, ALENDRONATE, ALLOPURINOL, SELBEX, NIZATIDINE. Patient recovered.

Velcade Side Effects Report #5346824-8
Velcade side effect was reported by a Physician from JAPAN on May 23, 2007. Female patient, 61 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: activities of daily living impaired, deep vein thrombosis , haemoglobin decreased, hypoaesthesia, lymphopenia, platelet count decreased, pulmonary embolism , pulmonary infarction, respiratory failure. Velcade dosage: 1.80 MG,. During the same period patient was treated with DEXAMETHASONE, PREDNISOLONE, SULFAMETHOXAZOLE, DIFLUCAN, ALENDRONATE, ALLOPURINOL, SELBEX, NIZATIDINE. Patient died.

Velcade Side Effects Report #5572377-5
Velcade side effect was reported by a Consumer or non-health professional from JAPAN on Dec 10, 2007. Male patient, 61 years of age, weighting 149.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: hypoaesthesia, pain . Velcade dosage: 2.20 MG, INTRAVENOUS. Patient recovered.

Velcade Side Effects Report #5608396-X
Velcade side effect was reported by a Consumer or non-health professional from JAPAN on Jan 15, 2008. Male patient, 61 years of age, weighting 149.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, constipation , hypoaesthesia, neuropathy peripheral, pain , platelet count decreased. Velcade dosage: 1.3 MG/M2; INTRAVENOUS, 2.29 MG, INTRAVENOUS. During the same period patient was treated with ZOMETA, PLATELETS. Patient recovered.

Velcade Side Effects Report #5893468-5
Velcade side effect was reported by a Physician from JAPAN on Sept 10, 2008. Male patient, 61 years of age, weighting 103.6 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, constipation , hepatic function abnormal, hypoaesthesia, lymphocyte count decreased, neutrophil count decreased, platelet count decreased, urinary retention, white blood cell count decreased. Velcade dosage: 1.76 MG, INTRAVENOUS, 1.70 MG, INTRAVENOUS, 1.4 MG, INTRAVENOUS, 1.39 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, FENTANYL, HARNAL. Patient died on 07/26/2008.


Velcade Side Effects Report #5928301-6
Velcade side effect was reported by a Physician from JAPAN on Oct 08, 2008. Male patient, 61 years of age, weighting 103.6 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, compression fracture, constipation , deformity, hepatic function abnormal, hypoaesthesia, ileus paralytic, lymphocyte count decreased, neurogenic bladder. Velcade dosage: 1.76 MG, INTRAVENOUS; 1.70 MG, INTRAVENOUS; 1.4 MG, INTRAVENOUS; 1.39 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, FENTANYL, HARNAL. Patient died on 07/26/2008.

Velcade Side Effects Report #5937666-0
Velcade side effect was reported by a Physician from JAPAN on Oct 17, 2008. Male patient, 61 years of age, weighting 103.6 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, hepatic function abnormal, hypoaesthesia, ileus paralytic, lymphocyte count decreased, neurogenic bladder, neutrophil count decreased, pneumonia , spinal compression fracture. Velcade dosage: 1.76 MG, INTRAVENOUS, 1.70 MG, INTRAVENOUS, 1.4 MG, INTRAVENOUS, 1.39 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, FENTANYL, HARNAL. Patient died on 07/26/2008.

Velcade Side Effects Report #6125917-1
Velcade side effect was reported by a Physician from JAPAN on Mar 06, 2009. Male patient, 61 years of age, weighting 103.6 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, constipation , hepatic function abnormal, hypoaesthesia, ileus paralytic, lymphocyte count decreased, neurogenic bladder, neutrophil count decreased, platelet count decreased. Velcade dosage: 1.76 MG, INTRAVENOUS; 1.70 MG, INTRAVENOUS, 1.4MG, INTRAVENOUS, 1.39 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, FANTANYL, HARNAL. Patient died on 07/26/2008.

Velcade Side Effects Report #4881316-1
Velcade side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 08, 2005. Female patient, 61 years of age, weighting 185.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal pain , bladder prolapse, constipation , decreased appetite, faecaloma, hypoaesthesia, nausea , umbilical hernia, vaginal laceration. Velcade dosage: unknown. During the same period patient was treated with DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4634906-5
Velcade side effect was reported by a Physician from on Mar 31, 2005. Male patient, 60 years of age, weighting 185.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: asthenia, chest pain , constipation , deep vein thrombosis , haemoglobin decreased, hypoaesthesia, intervertebral disc protrusion, lobar pneumonia, lymphocyte count decreased. Velcade dosage: 2.60 MG, INTRAVENOUS. Patient was hospitalized and became disabled. Patient recovered.

Velcade Side Effects Report #4881419-1
Velcade side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 16, 2005. Male patient, 60 years of age, weighting 185.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: chest pain , hypoaesthesia, neuropathy peripheral, pain in extremity, piloerection. Velcade dosage: unknown. During the same period patient was treated with FUROSEMIDE. Patient recovered.

Velcade Side Effects Report #5563331-8
Velcade side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 05, 2007. Male patient, 59 years of age, weighting 175.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal distension, aphonia, asthenia, blood potassium decreased, constipation , faecaloma, feeling abnormal, hypoaesthesia, muscle spasms. Velcade dosage: unknown. During the same period patient was treated with DEXAMETHASONE, ANTIFUNGALS, ANTIBIOTICS. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4881324-0
Velcade side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 15, 2005. Female patient, 59 years of age, weighting 229.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: burning sensation, hypoaesthesia, pain in extremity, paraesthesia. Velcade dosage: unknown. During the same period patient was treated with ALLOPURINOL, ALTACE, MAXZIDE, ACIPHEX, VITAMIN B6. Patient recovered.

Velcade Side Effects Report #5677061-5
Velcade side effect was reported by a Physician from JAPAN on Mar 05, 2008. Female patient, 58 years of age, weighting 97.00 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: bedridden, bone marrow failure, bronchopulmonary aspergillosis, condition aggravated, fungal infection , hepatic steatosis, herpes zoster, hypoaesthesia, liver disorder. Velcade dosage: 1.50 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, MUCOSTA, ALOSENN, VIT K CAP, RABEPRAZOLE, LOXONIN, HALCION, LASIX. Patient died on 04/10/2007.

Velcade Side Effects Report #5786832-6
Velcade side effect was reported by a Physician from JAPAN on June 11, 2008. Female patient, 58 years of age, weighting 97.00 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: fungal infection , hepatic steatosis, herpes zoster, hypoaesthesia, malaise, multi-organ failure, platelet count decreased, red blood cell count decreased, renal failure. Velcade dosage: 1.50 MG, INRAVENOUS. During the same period patient was treated with DEXAMETHASONE, KAMAG G, ALLOPURINOL, MUCOSTA, ALOSENN, VIT K CAP, RABEPRAZOLE, LOXONIN. Patient died on 04/10/2007.

Velcade Side Effects Report #5843432-7
Velcade side effect was reported by a Physician from JAPAN on July 31, 2008. Male patient, 58 years of age, weighting 154.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: diarrhoea, hypoaesthesia, influenza, neutrophil count decreased, platelet count decreased, skin exfoliation, white blood cell count decreased. Velcade dosage: 1.7 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, ADONA, LOPERAMIDE. Patient recovered.

Velcade Side Effects Report #5856422-5
Velcade side effect was reported by a Physician from JAPAN on Aug 12, 2008. Male patient, 58 years of age, weighting 154.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: diarrhoea, hypoaesthesia, influenza, lymphocyte count decreased, neutrophil count decreased, platelet count decreased, skin exfoliation, white blood cell count decreased. Velcade dosage: 1.7 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, ADONA, LOPERAMIDE. Patient recovered.

Velcade Side Effects Report #5894629-1
Velcade side effect was reported by a Physician from JAPAN on Sept 10, 2008. Male patient, 58 years of age, weighting 154.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: diarrhoea, hypoaesthesia, influenza, lymphocyte count decreased, neutrophil count decreased, platelet count decreased, skin disorder, skin exfoliation, white blood cell count decreased. Velcade dosage: 1.7 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, ADONA, LOPERAMIDE. Patient recovered.

Velcade Side Effects Report #5944220-3
Velcade side effect was reported by a Physician from UNITED STATES on Oct 23, 2008. Male patient, 58 years of age, weighting 160.5 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: amnesia, diarrhoea, disease progression, haemoglobin decreased, hypoaesthesia, paraesthesia, pneumonia , pulmonary embolism , septic embolus. Velcade dosage: 0.8 MG/M2,; 1.3 MG/M2,. During the same period patient was treated with DEXAMETHASONE, THALIDOMIDE, CISPLATIN, ADRIAMYCIN PFS, ADRIAMYCIN PFS. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5982052-0
Velcade side effect was reported by a Physician from UNITED STATES on Nov 20, 2008. Male patient, 58 years of age, weighting 160.5 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: amnesia, central line infection, deep vein thrombosis , diarrhoea, disease progression, disease recurrence, haemoglobin decreased, hypoaesthesia, neutrophil count decreased. Velcade dosage: 0.8 MG/M2, INTRAVENOUS, 1.3 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, THALIDOMIDE, CISPLATIN, ADRIAMYCIN PFS. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4616538-8
Velcade side effect was reported by a Consumer or non-health professional from on Feb 04, 2005. Female patient, 58 years of age, weighting 127.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: fatigue, feeling abnormal, hypoaesthesia, oedema peripheral, pain . Velcade dosage: 1.00 MG, 2/WEEK, INTRAVENOUS. During the same period patient was treated with THALIDOMIDE, ACYCLOVIR, FOLIC ACID, IRON, CALCIUM, VITAMINS, FISH OIL, DAPSONE. Patient recovered.

Velcade Side Effects Report #4692517-X
Velcade side effect was reported by a Consumer or non-health professional from on Mar 31, 2005. Female patient, 58 years of age, weighting 158.1 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: hypoaesthesia, neuropathy, pain in extremity, paraesthesia. Velcade dosage: unknown. During the same period patient was treated with ESTRADIOL. Patient recovered.

Velcade Side Effects Report #4822598-1
Velcade side effect was reported by a Physician from UNITED KINGDOM on Oct 20, 2005. Female patient, 57 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: balance disorder, blood cholesterol increased, blood urea decreased, dysphasia, fall , gamma-glutamyltransferase increased, gastroenteritis , hypoaesthesia, transient ischaemic attack. Velcade dosage: 1.30 MG/M2, 2/WEEK; IV BOLUS. During the same period patient was treated with ENALAPRIL, METFORMIN, GLICLAZIDE, BETAHISTINE, LEVOTHYROXINE, GABAPENTIN, VERAPAMIL. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5474882-9
Velcade side effect was reported by a Physician from JAPAN on Sept 20, 2007. Male patient, 56 years of age, weighting 180.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, constipation , hypoaesthesia, neurogenic bladder, neuropathy peripheral, platelet count decreased, pneumonia , tumour lysis syndrome, urinary retention. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DIFLUCAN, OMEPRAL, LEVOFLOXACIN, BROTIZOLAM, MAGNESIUM OXIDE, MONILAC, BAKTAR, SUCRALFATE. Patient recovered.

Velcade Side Effects Report #5689711-8
Velcade side effect was reported by a Physician from JAPAN on Mar 25, 2008. Male patient, 56 years of age, weighting 136.7 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal distension, alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, diarrhoea, hypoaesthesia, muscular weakness, neutrophil count decreased, pain . Velcade dosage: 1.90 MG, INTRAVENOUS. During the same period patient was treated with SENNOSIDE, ACYCLOVIR, ITRACONAZOLE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, PANTOSIN, MAGNESIUM OXIDE, FENTANYL, LAMIVUDINE. Patient died on 08/25/2007.

Velcade Side Effects Report #5746318-1
Velcade side effect was reported by a Physician from JAPAN on May 09, 2008. Female patient, 56 years of age, weighting 114.6 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal pain , anorexia, erythema, headache , hypoaesthesia, nausea , neutrophil count decreased, platelet count decreased, proteinuria. Velcade dosage: 1.98 MG, INTRAVENOUS, 1.5 MG, INTRAVENOUS, 1.1 MG, INTRAVENOUS, 1.5 MG, INTRAVENOUS. During the same period patient was treated with PREDNISOLONE, OMEPRAL, CALONAL, CLARITHROMYCIN, SULFAMETHOXAZOLE AND TRIMETHOPRIM. Patient recovered.

Velcade Side Effects Report #5746696-3
Velcade side effect was reported by a Physician from JAPAN on May 09, 2008. Male patient, 56 years of age, weighting 136.7 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal distension, alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, diarrhoea, hypoaesthesia, muscular weakness, neutrophil count decreased, pain . Velcade dosage: 1.90 MG, INTRAVENOUS. During the same period patient was treated with SENNOSIDE A, ACYCLOVIR, ITRACONAZOLE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, PANTOSIN, MAGNESIUM OXIDE, FENTANYL, LAMIVUDINE. Patient recovered.

Velcade Side Effects Report #6076293-4
Velcade side effect was reported by a Physician from JAPAN on Jan 29, 2009. Female patient, 56 years of age, weighting 114.6 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal pain , acne , anorexia, erythema, headache , hypoaesthesia, induration, nausea , neutrophil count decreased. Velcade dosage: 1.98 MG, INTRAVENOUS; 1.5 MG, INTRAVENOUS; 1.1 MG, INTRAVENOUS. During the same period patient was treated with PREDNISOLONE, OMEPRAZOLE, ACETAMINOPHEN, CLARITHROMYCIN, SULFAMETHOXAZOLE AND TRIMETHOPRIM. Patient recovered.

Velcade Side Effects Report #6084089-2
Velcade side effect was reported by a Physician from JAPAN on Feb 05, 2009. Male patient, 56 years of age, weighting 180.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, constipation , diarrhoea, disease progression, hypoaesthesia, lymphocyte count decreased, nervous system disorder, neurogenic bladder, neuropathy peripheral. Velcade dosage: 2.30 MG/M2, INTRAVENOUS; 1.70 MG, INTRAVENOUS; 2.20 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, DIFLUCAN, OMEPRAZOLE, LEVOFLOXACIN, BROTIZOLAM, MAGNESIUM OXIDE. Patient was hospitalized. Patient died on 05/30/2008.